Acute Myeloid Leukemia (AML) – Courtney DiNardo MD, and Robert Figlin, MD, discuss the latest clinical developments in AML

Acute Myeloid Leukemia (AML) – Courtney DiNardo MD, and Robert Figlin, MD, discuss the latest clinical developments in AML

Friday January 10, 2020

Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center and Courtney DiNardo, MD Associate Professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, discuss the latest clinical developments in AML

Featured Videos

Daneng Li, MD, on combining cabozantinib with checkpoint inhibitors to improve patient outcomes

Richard Kim, MD, on the combination of cabozantinib and checkpoint inhibitors to improve HCC outcomes

Peter M. Voorhees, MD, shares the current thinking regarding treatment algorithms in MM